Winslow Evans & Crocker’s BioAmber Inc. BIOA Stock Holding History

Winslow Evans & Crocker’s Portfolio BIOA Stock Details BIOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-600	Closed	-$1.79K	–	1328
2016 Q2	$1.79K	Hold	600	–	–	﹤0.01%	1183
2016 Q1	$2.52K	Hold	600	–	–	﹤0.01%	1135
2015 Q4	$3.71K	Hold	600	–	–	﹤0.01%	1127
2015 Q3	$3.21K	Sell	600 -150	-20%	-$991	﹤0.01%	1105
2015 Q2	$6.45K	Buy	750 +150	+25%	+$1.37K	﹤0.01%	1028
2015 Q1	$5.23K	Hold	600	–	–	﹤0.01%	1021
2014 Q4	$5.03K	Buy	600 +250	+71%	+$2.27K	﹤0.01%	1046
2014 Q3	$3.49K	Hold	350	–	–	﹤0.01%	1168
2014 Q2	$3.48K	Hold	350	–	–	﹤0.01%	1111
2014 Q1	$4K	Buy	+350	New	+$4.15K	﹤0.01%	1076

Other funds holding BIOA

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Robeco Schweiz Zurich, Switzerland $4.73B AUM 58.9% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Winslow Evans & Crocker's BIOA Position: Q3 2016 in Review

Winslow Evans & Crocker sold out of BioAmber Inc. (BIOA) in Q3 2016, closing a stake of 600 shares — an estimated $1.79K sold.

Winslow Evans & Crocker first reported a position in BIOA in Q1 2014 and held it in 10 quarters. The position peaked at $6.45K in Q2 2015. 33 funds tracked by Wall St. Rank hold BIOA as of Q3 2016.

Winslow Evans & Crocker reported no remaining BioAmber Inc. position as of Q3 2016 after selling out during the quarter.
Winslow Evans & Crocker sold 600 BioAmber Inc. shares in Q3 2016, an estimated $1.79K.
Winslow Evans & Crocker first reported a position in BioAmber Inc. in Q1 2014 and held it in 10 quarters.
Winslow Evans & Crocker's BioAmber Inc. position peaked at $6.45K in Q2 2015.
33 funds tracked by Wall St. Rank held BioAmber Inc. as of Q3 2016.

Based on Winslow Evans & Crocker's 13F filing for Q3 2016, filed 21 Oct 2016.